How Many Ozempic Pens Are in a Box? A Comprehensive Guide

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Patients prescribed GLP-1 therapy often wonder about Ozempic pen packaging and refill schedules. Understanding box contents helps with medication management and cost planning, especially since brand-name Ozempic and compounded semaglutide injections have different supply structures.

How Many Ozempic Pens Come in a Standard Box

Ozempic pens are dispensed in two main packaging configurations: single-pen boxes and four-pen multi-packs. A typical single-use pen delivers one fixed dose and cannot be refilled, meaning patients receive either one pen per prescription or four pens if they've selected a multi-pack option. The specific number depends on the pharmacy's inventory, the prescriber's instructions, and insurance coverage limits.

Most patients starting semaglutide therapy receive one pen per week for their initial titration phase. This means a four-week supply would require four separate pens. Some pharmacies bundle these into a four-pack box to simplify storage and tracking, while others dispense individual boxes weekly. The brand-name Ozempic pen cannot be reused after the last dose is gone, even if small amounts remain in the cartridge.

Difference Between Brand Ozempic and Compounded Semaglutide Injections

Brand-name Ozempic requires insurance approval or cash payment at retail prices often exceeding $900–$1,200 per pen, while PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of dose strength. Compounded formulations are prepared by licensed 503A compounding pharmacies and deliver the same active ingredient in customizable concentrations that match individual patient needs.

Compounded semaglutide offers a practical advantage: one month's supply arrives as a ready-to-inject vial or pen that lasts throughout the entire month as the dose is titrated upward. There is no need to manage multiple single-use pens or worry about inventory waste. PlexusDx pricing remains flat across all dose levels, meaning monthly cost stays consistent even as clinical response improves and dose adjustments occur.

Storage and Supply Management for Semaglutide Therapy

Whether using brand Ozempic pens or compounded semaglutide injections, proper refrigeration is essential. Both formulations should be stored at 36–46°F (2–8°C) before first use and can remain at room temperature up to 86°F (30°C) for up to 30 days once the pen is activated. Patients managing multiple pens may find a dedicated insulin cooler or pharmacy refrigerator organizer helpful for tracking expiration dates and injection schedules.

Compounded semaglutide from PlexusDx arrives in single-month supplies, eliminating the confusion of managing dozens of individual pens. The consistent monthly delivery model means patients receive fresh medication on schedule and never accumulate excess stock. This streamlined approach reduces waste and simplifies adherence tracking, especially for patients titrating up gradually over 8–12 weeks.

Access to Compounded Semaglutide Without Insurance Requirements

PlexusDx compounded semaglutide injections are available in all 50 states without insurance approval or membership fees. Pricing is $189 per month month-to-month, or from $149/mo on the 6-month plan and remains flat across three commitment tiers, meaning dose escalation never triggers a price increase. Patients can use Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA) to cover monthly costs, making precision weight loss therapy accessible regardless of insurance status.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How many Ozempic pens do I receive per month if I'm starting treatment?

Brand-name Ozempic pens are single-use only, so starting patients typically receive four individual pens per month during the titration phase. PlexusDx compounded semaglutide, by contrast, provides one month's supply in a single vial lasting the entire month, simplifying management and eliminating waste from unused pens.

Why does compounded semaglutide cost less than brand Ozempic?

Compounded semaglutide from licensed 503A pharmacies eliminates brand-name markup and insurance intermediaries. PlexusDx pricing is $189/mo month-to-month, or from $149/mo on the 6-month plan flat—no dose-based increases—while brand Ozempic often costs $900–$1,200 per pen. Both contain identical active ingredient, but compounding allows flexible, patient-friendly dosing and transparent pricing.

Can I use my HSA or FSA to pay for PlexusDx semaglutide injections?

Yes, PlexusDx compounded semaglutide injections are HSA/FSA eligible, making them an affordable option for eligible employees. Combined with the flat $189/month starting price and no insurance requirements, these accounts can meaningfully reduce out-of-pocket costs for personalized GLP-1 therapy.

Are compounded semaglutide injections as safe as brand Ozempic?

PlexusDx compounded semaglutide is prepared in licensed 503A compounding pharmacies under strict quality and sterility standards. Both formulations contain the same semaglutide molecule and work through identical GLP-1 receptor mechanisms. Individual safety and efficacy depend on proper dosing, monitoring, and patient-specific factors—not formulation source.

How does the Precision Peptide Genetic Test relate to my GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.